Eric Wieder
Impact in
- Virology top 0.5%
- HIV Research and Treatment
- Immunology top 1%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
Papers in
- Immunology 35
- Immune Cell Function and Interaction 21
- T-cell and B-cell Immunology 20
- Immunotherapy and Immune Responses 13
- Hematology 19
- Chronic Myeloid Leukemia Treatments 9
- Hematopoietic Stem Cell Transplantation 8
- Co-authors
- Krishna V. Komanduri (29 shared papers)Joseph M. McCune (7 shared papers)Jeffrey J. Molldrem (23 shared papers)Mary Beth Hanley (4 shared papers)Mohan Viswanathan (2 shared papers)Diane Schmidt (2 shared papers)Steven G. Deeks (2 shared papers)Marc K. Hellerstein (2 shared papers)
- Journals
- Blood (12 papers)Journal of Clinical Investigation (4 papers)Journal of Clinical Oncology (3 papers)The Journal of Immunology (3 papers)PLoS ONE (3 papers)
- Partner nations
- United StatesJapanFrance
In The Last Decade
Eric Wieder
72 papers receiving 4.0k citations
Eric Wieder's Hit Papers
Peers
Comparison fields: 5 of 118
- Virology 770
- Immunology 1.6k
- Hematology 813
- Oncology 902
- Genetics 213
Countries citing papers authored by Eric Wieder
This map shows the geographic impact of Eric Wieder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Wieder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Wieder more than expected).
Fields of papers citing papers by Eric Wieder
This network shows the impact of papers produced by Eric Wieder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Wieder. The network helps show where Eric Wieder may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric Wieder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 484 | |
| 2 | 1998 | 328 | |
| 3 | Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial Hit paper breakdown → | 2019 | 270 |
| 4 | 2007 | 232 | |
| 5 | 1999 | 203 | |
| 6 | 2000 | 202 | |
| 7 | 2003 | 174 | |
| 8 | 2019 | 138 | |
| 9 | 2003 | 132 | |
| 10 | 2002 | 113 | |
| 11 | 1994 | 101 | |
| 12 | 1995 | 94 | |
| 13 | 1998 | 90 | |
| 14 | 1996 | 83 | |
| 15 | 1998 | 79 | |
| 16 | 1993 | 76 | |
| 17 | 2016 | 74 | |
| 18 | 2004 | 73 | |
| 19 | 1993 | 72 | |
| 20 | 2008 | 70 |
About Eric Wieder
Eric Wieder is a scholar working on Immunology, Hematology, Molecular Biology, Oncology and Virology, having authored 73 papers that have together received 4.1k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (21 papers), T-cell and B-cell Immunology (20 papers), Immunotherapy and Immune Responses (13 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), Chronic Myeloid Leukemia Treatments (9 papers), HIV Research and Treatment (9 papers), Hematopoietic Stem Cell Transplantation (8 papers) and CAR-T cell therapy research (6 papers). The work is most often cited by research in Virology (770 citations), Immunology (1.6k citations), Hematology (813 citations), Oncology (902 citations) and Genetics (213 citations). Eric Wieder has collaborated with scholars based in United States, Japan and France. Frequent co-authors include Krishna V. Komanduri, Joseph M. McCune, Jeffrey J. Molldrem, Mary Beth Hanley, Mohan Viswanathan, Diane Schmidt, Steven G. Deeks, Marc K. Hellerstein, Richard A. Neese and Rebecca Hoh. Their work appears in journals such as Blood, Journal of Clinical Investigation, Journal of Clinical Oncology, The Journal of Immunology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.